8-K filing — Endovia Health Sciences, Inc. (EDVA)
Filed: 2026-10-06 AccNo: 0001731122-26-001320 Size: 186 KB Item 3.02: Unregistered Sales of Equity Securities
Stocks · News reference
Endovia Health Sciences Says FDA Center For Veterinary Medicine Established Investigational New Animal Drug File No. 14145 For CannEpil In Canine Cancer-Related Pain
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Endovia Health Sciences And Lupvindol BioSciences Receives FDA Determination That Proposed Use Of Cannepi For Control Of Pain Associated With Bone Cancer In Dogs Qualifies As 'Minor Use'
Center for Veterinary Medicine has determined that the proposed use of CannEpil®, an investigational cannabidiol ("CBD") and tetrahydrocannabinol ("THC") oral solution, for the control of pain associated
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Worthington Enterprises surged 15.9% premarket after beating Q1 EPS and sales estimates; Wheeler REIT led gainers, while Jaguar Health and Biomea fell.
Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On
Endovia Health Sciences shares jumped 47.83% after hours Tuesday as investors cheered fresh funding for its CannEpil drug program.